Our next example is a phase I trial that included stage IV pancreatic cancer patients receiving IVC, gemcitabine, and erlotinib. After 8 weeks of treatment, 88% of the patients experienced a decrease in primary tumor size. The researchers noted these are incredible results that are superior to “gemcitabine alone or gemcitabine plus erlotinib”.

Visit our channel to learn more:
[ Ссылка ]

Go here to schedule a IVC free consultation:
[ Ссылка ]

Access this link to learn more about IVC treatment:
[ Ссылка ]

High Dose Vitamin C Cancer Treatment Guide:
[ Ссылка ]

Facebook page:
[ Ссылка ]

Links to studies and articles referenced in the video:
[ Ссылка ]
[ Ссылка ]

Disclaimer: The information and referenced resources are for educational purposes only. The information is not intended to provide personal medical or health advice. The contents of the video or description is not a substitute for medical or health advice from a professional who is aware of the facts and circumstances of your individual situation. Information provided by the host of the video or the use of any products or services mentioned does not create a practitioner-patient relationship between you and any person affiliated with this production.

свернуть